Have you ever been running late for work, your hand extended into your shower, cursing its name as the water slowly warms to a temperature that would allow you to enter? Well, you may be being unsympathetic to your hot water heater, because it's likely running all day and all night to keep between 40-80 gallons of water heated, so it can be ready at your command. As you ponder the inefficiency of such a system, imagine the hot water needs of a hotel or a high-rise apartment building, with hundreds of rooms and thousands of inhabitants. The founder in this week's Silicon Valley Insider, Sridhar Deivasigamani, estimates that at any point in time in the US, there could be as much as 6 billion gallons of water being kept hot for our consumption, one-sixth the size of Lake Tahoe. Intellihot, the Galesburg, IL company founded in 2009, designs and manufactures tankless water heaters, as well as monitoring devices and apps, for residential, commercial and industrial applications.
Tank warfare isn't traditionally easy to predict. In July 1943, for instance, German military planners believed that their advance on the Russian city of Kursk would be over in ten days. In fact, that attempt lasted nearly two months and ultimately failed. Even the 2003 Battle of Baghdad, in which U.S. forces had air superiority, took a week. The U.S. Army has launched a new effort, dubbed Project Quarterback, to accelerate tank warfare by synchronizing battlefield data with the aid of artificial Intelligence.
Former Trump campaign trade and jobs adviser Curtis Ellis on what this means for the trade deal. For many decades, Americans thought communist-ruled China would evolve into a free and open system similar to our own. In truth, Xi Jinping became the general secretary of the People's Republic of China and chairman of the Central Military Commission in November 2012. He became the president of the People's Republic of China in March 2013. During Xi's tenure, there has been a significant increase in censorship and mass surveillance, a significant deterioration in human rights, and the removal of term limits for the Chinese presidency.
SAN DIEGO (KGTV) - Behind every mammogram Dr. Lisa Watanabe looks at is a woman waiting, and hoping, for good news. Dr. Watanbe is a radiologist, and the Chief Medical Officer for CureMetrix, an artificial intelligence (AI) technology company focused on early breast cancer detection. Their FDA-cleared software is able to learn, using millions of mammograms, to identify, mark, and score anomalies. "Cancers that were missed by a radiologist were detected by the machine, some of them weren't even small, sometimes they were just obscured by dense tissue," said Dr. Watanabe. She says the technology has found breast cancer up to five years earlier than it was found by the human radiologist.
After expanding its "all-in-one" AI bundle, which includes 3 FDA 510(k) clearances, the deep learning medical imaging analytics company, Zebra Medical Vision, is now announcing a new joint partnership with Intelerad Medical Systems, a leader in enterprise workflow solutions. The joint program will leverage Intelerad's newly released Odyssey designed to encourage the adoption of artificial intelligence without the prohibitive costs usually associated with such programs. The positive impact of artificial intelligence technology has been demonstrated in many fields, including that of radiology. Indeed, AI can help radiologists increase productivity, improve clinical decisions and, ultimately, provide high-quality care when the technology is tightly managed and smartly integrated in the workflow. Odyssey harnesses the power of artificial intelligence and the technology behind the Intelerad worklist to offer an unparalleled workflow management solution, comprised of the clinical AI engine, powered by Zebra-med's AI1 "all-in-one" bundle of FDA cleared AI applications.
Amplion, a leading precision medicine intelligence company, has released Dx:Revenue, a groundbreaking software solution that enables test providers to identify ideal pharmaceutical partnership opportunities at the right time to advance precision medicine collaboration. Dx: Revenue is an extension of Amplion's core business intelligence platform that leverages proprietary machine learning to deliver tailored insights into pharma and test developer activities. The platform draws from more than 34 million evidence sources such as clinical trials, scientific publications, conference abstracts, FDA cleared and approved tests, lab developed tests, diagnostic and drug pipelines and more in real time, producing prioritized and timely partnering opportunities that are a precise match between a test provider's capabilities and pharma's specific needs. "Precision medicine has a problem," says Chris Capdevila, CEO, Amplion. "There is an insurmountable volume of information with the potential to drive the realization of precision medicine for patients, but accessing that information strategically, effectively and quickly to make the best pharma partnering decisions is beyond human scale. Our company was founded to address this issue by providing critical evidence-based intelligence that supports the strategic decisions pharmaceutical and test developers need to make to be successful."
We thank Twist Bioscience for synthesizing and cloning ChR sequences, D. Wagenaar (California Institute of Technology) and the Caltech Neurotechnology Center for building the mouse treadmill, J. Brake (California Institute of Technology) for performing spectrometer measurements, J. Bedbrook for critical reading of the manuscript and the Gradinaru and Arnold laboratories for helpful discussions. This work was funded by the Institute for Collaborative Biotechnologies grant no. W911NF-09-0001 from the US Army Research Office (F.H.A) and the National Institutes of Health (NIH) (V.G.): NIH BRAIN grant no. RF1MH117069, NIH Director's Pioneer Award grant no. DP1NS111369, NIH Director's New Innovator Award grant no.
Every summer there is a mass exodus from New York City towards the white beach at Jones Beach State Park. Here, looking out over the Atlantic Ocean, you can sunbathe, catch a concert or play a game of mini-golf. And get away from the bustle of the city. But you have to get there first. And there's something odd about the route you take. The flyovers over the Southern State Parkway that leads to Jones Beach are low.
By 2030 the total gross domestic product of the world will be 14% higher because of one thing: more use of artificial intelligence or AI. That's the conclusion of PwC, a professional services firm based in London. If such forecasts are right these sophisticated computer programs will be doing tasks such as driving vehicles, planning and waging wars, and advising humans on how to handle both their health and wealth. One observer writing in the Journal of the American Medical Association has declared that the "hype and fear" surrounding AI "may be greater than that which accompanied the discovery of the structure of DNA or the whole genome." Yet despite the possibility of colossal impacts from AI, the U.S. government has been doing little to study its ethical implications.